Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
MicroStrategy confronts a pivotal test as its Bitcoin treasury faces a brutal market. With BTC below its purchase pri...
As rates cool, Angel Oak’s Hutchens charts a growth path for non-QM lending with a sharper focus on product expansion...
The post-IPO market is buzzing about Swarmer, but excitement can blur judgment. Here are three practical realities ev...
Investors are focused on ducommun (dco) 2026 earnings as Q1 sets the tone for the year. This article explains how to ...
When a major holding shows a sharp fall after earnings, investors scramble for answers. This guide breaks down the re...
A five-month surge has transformed a $10,000 stake in XLK into roughly $13,450, outpacing the S&P 500 and signaling A...
A growing number of retirees are choosing to stay in Chicago, turning a local lifestyle into a cost-saving retirement...
A new look at college pricing shows that the real reason college costs stay high isn’t tuition alone. Living costs an...
Global Payments stunned the market with a strong earnings beat and optimistic guidance, triggering a sharp stock move...
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
As the Fed's path becomes less predictable, investors weigh how many rate cuts to expect in 2026. This guide breaks d...